Skip to Content

Crimson/OCD

M/14/004

Completed

Transaction details

The proposed acquisition of sole control of the Ortho Clinical Diagnostics business by Crimson Bermuda Co. Limited has been cleared by the Competition Authority.
Case details
  • Notification date:4 February 2014
  • Publication date:4 February 2014
  • Economic sector:Manufacturing - C
  • Economic sub-sector:Manufacture of electronics - C.26
  • Outcome:Cleared
Documents
Timetable

Phase One

  • Tuesday, 4 February, 2014 Notification received
  • Monday, 17 February, 2014 Third party submission deadline
  • Thursday, 27 February, 2014 Determination issued
Parties Involved

Crimson Bermuda Co. Ltd

Crimson is a company controlled by funds managed by affiliates of The Carlyle Group. Carlyle is a global alternative asset manager.

 

Ortho Clinical Diagnostics

OCD is a provider of IVD systems.

Contacts
View all mergers